Assignee
NUCLIDIUM AG
CH·2 granted patents·3 pending applications·0 citations·filing 2023–2025
Top patents by PatentIndex Score
5 records- 0158US12447217B2Fibroblast activation protein (FAP) inhibitors, FAP conjugates, and diagnostic and therapeutic uses thereofNUCLIDIUM AG·Filed 2023·Granted Oct 21, 2025·0 cites·33 claims
- 0258US2026061084A1Fibroblast activation protein (fap) inhibitors, fap conjugates, and diagnostic and therapeutic uses thereofNUCLIDIUM AG·Filed 2025·Application pending·0 cites
- 0348US12527885B2High purity copper radiopharmaceutical compositions and diagnostic and therapeutic uses thereofNUCLIDIUM AG·Filed 2023·Granted Jan 20, 2026·0 cites·69 claims
- 0444US2024161939A1Solid target systems for the production of high-purity radionuclide compositionsNUCLIDIUM AG·Filed 2023·Application pending·0 cites
- 0543US2024189460A1High purity copper radiopharmaceutical compositions and diagnostic and therapeutic uses thereofNUCLIDIUM AG·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NUCLIDIUM AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →